BioCentury | May 30, 2020
Finance

Daily Chart: May follow-on frenzy

May ended with a whopping $9 billion in follow-on capital raised for life sciences companies, more than the four previous months combined. The follow-on market had gone largely quiet in March and April as the...
BioCentury | Nov 22, 2010
Clinical News

Pioneer regulatory update

...is combination device comprising a cobalt-chromium coronary stent and the Protégé DEB that delivers paclitaxel. Blue Medical B.V....
BioCentury | Nov 22, 2010
Clinical News

Protégé regulatory update

...is combination device comprising a cobalt-chromium coronary stent and the Protégé DEB that delivers paclitaxel. Blue Medical B.V....
Items per page:
1 - 3 of 3
BioCentury | May 30, 2020
Finance

Daily Chart: May follow-on frenzy

May ended with a whopping $9 billion in follow-on capital raised for life sciences companies, more than the four previous months combined. The follow-on market had gone largely quiet in March and April as the...
BioCentury | Nov 22, 2010
Clinical News

Pioneer regulatory update

...is combination device comprising a cobalt-chromium coronary stent and the Protégé DEB that delivers paclitaxel. Blue Medical B.V....
BioCentury | Nov 22, 2010
Clinical News

Protégé regulatory update

...is combination device comprising a cobalt-chromium coronary stent and the Protégé DEB that delivers paclitaxel. Blue Medical B.V....
Items per page:
1 - 3 of 3